Roche targets becoming top 3 obesity player as experimental drug enters late-stage trial - CNBC
#obesity player#Roche targets#experimental drug#drug enters#enters late-stage
Life Science News
Latest updates from the biotech and pharma world
RION Engages Lonza to Scale Manufacturing Exosome Based Therapeutics - Business Wire
#Engages Lonza#Scale Manufacturing#Manufacturing Exosome#Exosome Based#RION Engages
RION Partners with Lonza for Scalable Exosome-Based Drug Manufacturing - Contract Pharma
#RION Partners#Drug Manufacturing#Contract Pharma#Scalable Exosome-Based#Exosome-Based Drug
Lonza Agrees to Scale Manufacturing for RION’s Exosome-Based Therapeutics - GEN - Genetic Engineering and Biotechnology News
#Genetic Engineering#Scale Manufacturing#Lonza Agrees#Therapeutics GEN#Exosome-Based Therapeutics
Geriatrician Roche appointed Professor Emeritus of Internal Medicine - UT Southwestern Medical Center
#Professor Emeritus#Southwestern Medical#Internal Medicine#Medical Center#Geriatrician Roche
Roche pushes a novel myeloma target | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
#Clinical Trials#Oncology Pipeline#myeloma target#Roche pushes#Pipeline Roche
Roche's 'top three' obesity ambition not reliant on developing one megablockbuster - Fierce Biotech
#Fierce Biotech#obesity ambition#Biotech Roche#megablockbuster Fierce#top
Roche looks earlier with divarasib | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
#Clinical Trials#Oncology Pipeline#Pipeline Roche#ApexOnco#analysis Oncology
Illumina to develop KRAS companion diagnostics with multiple pharma partners - FirstWord Pharma
#develop KRAS#KRAS companion#multiple pharma#companion diagnostics#pharma partners
Illumina advances personalized cancer care with new pharma development partnerships - PR Newswire
#Illumina advances#advances personalized#personalized cancer#cancer care#pharma development
Thermo Fisher Scientific’s Valuation: Assessing New Launches and Upgraded Outlook - Yahoo Finance
#Fisher Scientific#Upgraded Outlook#Yahoo Finance#Thermo Fisher#Outlook Yahoo
Here's Why Lonza Group (LZAGY) Is a Great 'Buy the Bottom' Stock Now - Nasdaq
#Lonza Group#LZAGY#Group#Great#Buy
Here's Why Lonza Group (LZAGY) Is a Great 'Buy the Bottom' Stock Now - Yahoo Finance
#Lonza Group#Yahoo Finance#LZAGY#Group#Great
Roche, muscling into weight-loss drug race, advances obesity treatment to late-stage trial - Reuters
#drug race#advances obesity#weight-loss drug#obesity treatment#Reuters Roche
Roche CEO, pharma execs to meet with Swiss government over US tariffs - Reuters
#Roche CEO#Swiss government#pharma execs#Reuters Roche#CEO
Illumina sued by rival Element over gene-sequencing technology - Reuters
#rival Element#Illumina sued#gene-sequencing technology#Reuters Illumina#technology Reuters
Lunit and Agilent Technologies Announce Collaboration to Enhance Development of Companion Diagnostic Solutions Powered with AI for Precision Medicine - PR Newswire
#Agilent Technologies#Technologies Announce#Announce Collaboration#Enhance Development#Companion Diagnostic
Thermo Fisher Scientific Launches the Thermo Scientific Hypulse Surface Analysis System to Accelerate the Understanding of Material Surfaces - Business Wire
#Analysis System#Fisher Scientific#Scientific Launches#Scientific Hypulse#Hypulse Surface
Jessup Lonza Club serves up first Lonza competition - fox56.com
#Jessup Lonza#Lonza Club#Lonza competition#Club serves#Lonza
Jason Berndt ’01 Joins Lonza as New Head of Group Operations, Executive VP - West Point Association of Graduates
#Group Operations#Joins Lonza#Point Association#West Point#Jason Berndt